Next Generation Processing Technologies For Oral Solid Dosage (OSD) Forms

GEA Pharma Systems, G-CON and Pfizer collaborate to develop innovative, next generation processing technologies for oral solid dosage (OSD) forms. Designed to address the rapidly changing requirements of pharmaceutical development and manufacturing, PCMM (Portable Continuous Miniature and Modular) manufacturing aims to meet the industry’s needs for continuous processing in a flexible, self-contained manufacturing space. PCMM comprises a system that integrates a small footprint, continuous processing equipment, smart control systems and PODs (portable, self-contained GMP modules) to process API powders and inactive ingredients into to bulk tablets.

Source: Pharmaceutical Online News - March 4, 2016 Category: Pharmaceuticals Source Type: news